Gilead Provides Update on Phase 3 ASCENT-07 Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/12/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. SPCX
9. TLT
10. PMTS

Go back to Gilead Provides Update on Phase 3 ASCENT-07 Study
Gilead Sciences (NASDAQ: GILD) Delayed: 143.72 -1.09 (0.75%)
Previous Close $144.81    52 Week High $108.63 
Open $145.24    52 Week Low $71.39 
Day High $145.99    P/E 79.40 
Day Low $143.50    EPS $1.81 
Volume 4,216,026